Kikuchi-Fujimoto disease essentially always shows partial LN involvement!
T cells in involved areas are predominantly CD8+.
How to avoid overdiagnosis as lymphoma:
1) Remember KFD!
2) Never diagnose "partial LN involvement by CD8+ PTCL"...that's KFD (or lupus lymphadenopathy) https://t.co/GxVUjLlOqX
Adult Cystic Nephroma
🩺 F>M (7:1)
Currently classified as part of MEST tumour family (CN entirely cystic; MEST cystic and solid)
🔬Biphasic multicystic tumour:
🔸Fibrous, often ovarian-type stroma: ER/PR +
🔸Cuboidal/hobnail cyst epithelial lining
#gupath#pathresidents
#PathTwitter#Pathologists#OpportunityAlert
We need a couple of creative pathologists who can use BioRender and / or Adobe Illustrator to make illustrations for our books. Since you will be creating content, you will be given author and illustrator credits. This is a good opportunity to show your creative skills. Message us here or contact us at [email protected].
#ComeAceWithUs! #AceTheBoards #Pathology #pathX
Adenomatoid tumor in a fallopian tube. Notice the thread-like bridging strands of cytoplasm in the second picture. This benign mesothelium-derived tumor was calretinin-positive.
#PathTwitter#pathoutpic
Morphology remains critical in the genomic era; Two lesions of the gastric muscularis propria with MALAT1-GLI1 fusions; one (gastroblastoma) is malignant and the other (plexiform fibromyxoma) benign.
4/ If anti-HLA antibodies are present in a potential recipient's serum, they will bind to the beads. After washing, a secondary anti-IgG fluorescent antibody is added.
Then, we can quantify the fluorescence using the MFI (mean fluorescent intensity) ⚡️⚡️⚡️
#Luminex#HLA
Excited to share our recently published case report on MPAL! Grateful to my attending and co-residents for their guidance and support throughout the process. Check it out here: https://t.co/YhH2GKOBMa
#Hematopathology❤️
I'm ecstatic to share that my first case report has been published! Grateful for the mentorship from Drs. @Brenda_Path and Armstrong, as well as the support of my amazing coresidents @nourhan_path22 and @AAMDPath. @UTHoustonPath https://t.co/40VmVHLY5D